Top Canadian Cannabis Stocks to Watch This Week
Canada’s leading cannabis firms with U.S. exposure are gaining fresh attention. Their ability to bridge both markets gives them an advantage. Moreover, U.S. policy shifts could provide new momentum. Rescheduling marijuana to a lower classification may ease banking access. In addition, that change would reduce tax burdens for licensed businesses. These potential reforms could unlock stronger growth.
Meanwhile, the U.S. legal cannabis market is expanding rapidly. Sales are projected to rise from about $37 billion in 2024 to $91 billion by 2033. Therefore, the growth suggests a strong annual rate of more than 10 percent. Canadian companies with U.S. operations are positioned to benefit. They offer investors both cross-border reach and global branding. As a result, traders are watching these names closely this week.
Furthermore, recent legalization headlines have fueled optimism. Political leaders are considering reclassifying marijuana at the federal level. That shift could open new funding options and reduce restrictions. Cannabis stocks rallied strongly after this news. Consequently, traders now look for follow-through momentum.
Technical analysis is useful in such volatile conditions. Support and resistance levels can highlight potential entry points. Indicators like RSI help confirm overbought or oversold conditions. Equally important, risk management is essential. Setting stop-loss orders protects capital from sharp reversals. Position sizing should remain modest to reduce exposure. Together, these strategies allow disciplined participation in a high-potential but risky sector.
[Read More] Cannabis Stock Outlook 2025: Ayr Wellness, Ascend Wellness, and Cresco Labs
Top 3 Canadian Cannabis Stocks to Watch in August 2025
- Tilray (NASDAQ: TLRY)
- Village Farms International (NASDAQ: VFF)
- Canopy Growth (NASDAQ: CGC)
Tilray (TLRY)
Tilray is one of the world’s largest cannabis companies. It operates across Canada, the U.S., and other international markets. In particular, Tilray focuses on cannabis-adjacent consumer goods within the United States. Its beverage division has become a key growth driver. It also participates in cultivation and distribution through partners. The company’s presence in U.S. dispensaries continues to expand.
Tilray’s cross-border operations provide scale and flexibility. Moreover, its beverage brands have reached mainstream retail shelves. That gives Tilray an edge over peers. Additionally, its strategy balances both recreational and medical cannabis markets. Tilray is viewed as a bridge between Canadian legalization and U.S. potential. Therefore, its presence in consumer products and cannabis makes it uniquely positioned.
Latest Financials
Tilray recently reported annual revenue of over $820 million. That represented growth compared with the previous year. However, it also recorded a significant net loss of more than $2 billion. Despite this, some divisions performed strongly.
Beverage alcohol sales increased steadily. One quarter showed $63 million in revenue, with strong gross profit expansion. Gross margins improved across the business, reaching nearly 30 percent. In fact, the beverage segment posted margins of around 40 percent. This indicates strong consumer demand and pricing power.
Analysts remain cautious but see room for recovery. Revenue growth suggests demand is firming. Yet, losses highlight the need for tighter cost control. For investors, Tilray offers growth potential with elevated risk. Thus, proper chart analysis and disciplined risk management are key when trading TLRY shares.
[Read More] 3 Top Marijuana Stocks For Better Investing In The Cannabis Sector
Village Farms International (VFF)
Village Farms International operates large-scale greenhouses. It supplies cannabis in both Canada and the U.S. The company is known for efficient greenhouse cultivation. Unlike some peers, Village Farms focuses more on production than retail.
Its U.S. operations emphasize wholesale supply. The company provides cannabis flower and extracts to licensed retailers. Rather than owning many dispensaries, it follows a business-to-business model. This reduces capital costs and lowers risk. Nevertheless, it controls significant production volumes. That makes it an important supplier in key U.S. states.
Village Farms’ greenhouse expertise allows for consistent year-round output. Efficiency in cultivation remains a core advantage. Therefore, as U.S. demand expands, Village Farms is positioned to scale. Its focus on cost management and production capacity keeps it competitive.
Latest Financials
Recent financial results show steady progress. Canadian cannabis sales increased year over year. Furthermore, the industry as a whole has also grown steadily in 2025. Village Farms benefits from this rising demand.
Although detailed numbers remain limited, revenue has been expanding. Consequently, investors expect continued growth from larger volumes and better pricing. Profitability trends remain important to watch. Margins are improving as production efficiency rises.
Capital spending has been managed carefully, which reduces debt pressures. For this reason, traders should monitor upcoming earnings reports. Technical analysis can help track potential breakouts. Applying stop-loss levels is important to manage volatility.
Village Farms does not grab as many headlines as larger peers. Even so, its operational strength makes it a reliable contender. The company’s U.S. presence, greenhouse expertise, and cost structure provide resilience. Therefore, investors seeking a production-focused cannabis play often consider VFF.
[Read More] Top Ancillary Cannabis Stocks to Watch This Week as U.S. Legalization Momentum Builds
Canopy Growth (CGC)
Canopy Growth is another Canadian cannabis leader. It is well known for its broad product portfolio. The company sells flower, pre-rolls, edibles, and wellness products. Moreover, it owns Storz & Bickel, a premium vaporizer brand. That business strengthens Canopy’s U.S. presence through devices and accessories.
Direct U.S. dispensary ownership is limited. However, Canopy’s products reach American shelves through licensing and partnerships. Its wide product range ensures strong brand visibility. Additionally, its device segment provides diversification outside traditional cannabis.
Canopy’s strategy blends Canadian retail dominance with global expansion. As U.S. regulations evolve, its presence could become more valuable. The combination of cannabis, consumer goods, and devices creates multiple revenue streams. Thus, this diversification gives Canopy a balanced approach to growth.
Latest Financials
Canopy recently reported mixed results. Canadian medical cannabis sales grew strongly, reaching $77 million. International medical sales declined slightly, showing weakness abroad. On the other hand, its Storz & Bickel unit grew revenues by 4 percent.
Gross margins expanded by 300 basis points year over year. Adjusted EBITDA improved by nearly 40 percent. At the same time, the company reduced total debt by almost half. This represents major progress in strengthening its balance sheet.
Still, challenges remain. Net revenues have been pressured, and losses continue. Investor sentiment remains cautious. Nevertheless, margin recovery and debt reduction are positives.
For traders, Canopy Growth offers both risk and opportunity. Its financial restructuring signals progress, but profitability is not yet secure. Therefore, technical indicators can highlight potential reversals or momentum shifts. Risk controls, including stop-losses, remain essential when trading CGC.
Top Canadian Pot Stocks With US Growth
Tilray, Village Farms, and Canopy Growth each offer unique strengths. Tilray leads with beverage expansion. Village Farms brings cultivation efficiency. Canopy Growth is showing margin recovery and debt reduction.
The U.S. cannabis market continues to expand. Sales could climb from about $37 billion in 2024 to more than $91 billion by 2033. Canadian firms with U.S. exposure are set to benefit. In addition, U.S. rescheduling could reduce restrictions and boost valuations.
However, volatility remains high. Technical analysis can provide trading signals. Risk management helps protect capital. Position sizing, stop-loss orders, and careful timing all matter. Ultimately, with discipline, investors can participate in the sector’s growth story while limiting downside risk.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
